17 Dec 2019
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/armgo-pharma-inc-announces-clinical-trial-of-arm210s48168-for-the-treatment-of-ryanodine-receptor-type-1-related-myopathies-300975427.html
06 Sep 2018
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/armgo-pharma-receives-fda-orphan-drug-designation-for-arm210s48168-for-the-treatment-of-ryanodine-receptor-type-1-related-myopathies-300707183.html